Clough Capital Partners L P Has $14.09 Million Position in UnitedHealth Group Incorporated $UNH

Key Points

• Clough Capital Partners L P significantly increased its holdings in UnitedHealth Group by 153.4%, acquiring 16,279 shares during the 1st quarter, boosting its total to 26,894 shares.
• UnitedHealth Group's shares experienced volatility, opening at $302.66, with an average price target of $353.00 according to analysts, and facing mixed ratings from various research firms.
• The company declared a quarterly dividend of $2.21 per share, representing an annualized yield of 2.9%, set to be paid on September 23rd.

Clough Capital Partners L P grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 153.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,894 shares of the healthcare conglomerate's stock after purchasing an additional 16,279 shares during the quarter. UnitedHealth Group makes up 1.8% of Clough Capital Partners L P's portfolio, making the stock its 21st largest holding. Clough Capital Partners L P's holdings in UnitedHealth Group were worth $14,086,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. Bayforest Capital Ltd grew its holdings in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its holdings in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares in the last quarter. IAG Wealth Partners LLC acquired a new stake in UnitedHealth Group in the 1st quarter valued at approximately $42,000. Kapitalo Investimentos Ltda acquired a new stake in UnitedHealth Group in the 4th quarter valued at approximately $41,000. Finally, Copia Wealth Management acquired a new stake in UnitedHealth Group in the 4th quarter valued at approximately $42,000. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research reports. Oppenheimer decreased their price target on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Wolfe Research decreased their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. Hsbc Global Res lowered UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Mizuho reduced their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Finally, HSBC reissued a "reduce" rating and set a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Fifteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $353.00.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Up 2.5%

Shares of UnitedHealth Group stock traded up $7.48 during midday trading on Friday, hitting $309.77. The company's stock had a trading volume of 12,018,847 shares, compared to its average volume of 20,287,358. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The stock has a 50-day simple moving average of $288.16 and a 200-day simple moving average of $380.68. The firm has a market capitalization of $280.55 billion, a P/E ratio of 13.42, a PEG ratio of 2.00 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the prior year, the business posted $6.80 earnings per share. UnitedHealth Group's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.